Using the North Dakota Immunization Information System to determine adolescent vaccination rates and uptake

Public Health Reports

Volumn 126, Issue SUPPL. 2, 2011, Pages 78-86

  LoMurray, Keith ^a   Sander, Molly ^a  

^a North Dakota Department of Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MENINGOCOCCUS VACCINE; VACCINE; WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; EDUCATION; FEMALE; HUMAN; IMMUNIZATION; INFORMATION SYSTEM; MALE; PRIORITY JOURNAL; SCHOOL; UNITED STATES; VACCINATION; AGE; HEALTH SURVEY; REGISTER; STATISTICS;

ADOLESCENT; AGE FACTORS; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MENINGOCOCCAL VACCINES; NORTH DAKOTA; PAPILLOMAVIRUS VACCINES; REGISTRIES; VACCINES;

EID: 80052060249     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/00333549111260s210     Document Type: Article

References (33)

1. Recommended childhood and adolescent immunization schedule-United States, January-June 2004. MMWR Morb Mortal Wkly Rep 2004;53(01):Q1-4.
2. Hall S, Galil K, Watson B, Seward J. The use of school-based vaccination clinics to control varicella outbreaks in two schools. Pediatrics 2000;105:e17.
3. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2005;54(RR-7):1-21.
4. Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2006;55(RR-3):1-34.
5. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2007;56(RR-2):1-24.
6. Recommended immunization schedules for persons aged 0 through 18 years-United States, 2010. MMWR Morb Mortal Wkly Rep 2010;58(51&52):1-4.
7. Shefer A, Santoli J, Singleton JA. Measuring vaccination coverage-where are we now and where are we going? J Public Health Manag Pract 2007;13:541-3.
8. Smith PJ, Battaglia MP, Huggins VJ, Hoaglin DC, Roden AS, Khare M, et al. Overview of the sampling design and statistical methods used in the National Immunization Survey. Am J Prev Med 2001;20(4 Suppl):17-24.
9. Immunization data. N.D.C.C. §23-01.05.3 (2010) [cited 2011 Mar 17]. Available from: URL: http://www.legis.nd.gov/cencode/ t23c01.pdf
10. Centers for Disease Control and Prevention (US). Q&A about sentinel sites: what are IIS sentinel sites? [cited 2010 Apr 15]. Available from: URL: http://www.cdc.gov/vaccines/programs/iis/activities/ sentinel-sites.htm#what
11. Census Bureau (US). Population estimates: state single year of age and sex population estimates: April 1, 2009, to July 1, 2009 [cited 2010 Jan 7]. Available from: URL: http://www.census.gov/popest/ states/asrh/stasrh.html
12. National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2008. MMWR Morb Mortal Wkly Rep 2009;58(36):997-1001.
13. Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Parental vaccine safety concerns in 2009. Pediatrics 2010;125:654-9.
14. National Vaccine Advisory Committee. Mandates for adolescent immunizations: recommendations from the National Vaccine Advisory Committee. Am J Prev Med 2008;35:145-51.
15. Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009;302:750-7.
16. Forhan SE, Gottlieb SL, Sternberg MR, Xu F, Datta SD, McQuillan GM, et al. Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics 2009;124:1505-12.
17. LeBaron CW, Mercer JT, Massoudi MS, Dini E, Stevenson J, Fischer WM, et al. Changes in clinic vaccination coverage after institution of measurement and feedback in 4 states and 2 cities. Arch Pediatr Adolesc Med 1999;153:879-86.
18. Inoculation required before admission to school. N.D.C.C. §23-07.17.1 [cited 2011 Mar 17]. Available from: URL: http://www. legis.nd.gov/cencode/t23c07.pdf
19. Averhoff F, Linton L, Peddecord KM, Edwards C, Wang W, Fishbein D. A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health 2004;94:978-84.
20. Wilson TR, Fishbein DB, Ellis PA, Edlavitch SA. The impact of a school entry law on adolescent immunization rates. J Adolesc Health 2005;37:511-6.
21. Schwartz JL, Caplan AL, Faden RR, Sugarman J. Lessons from the failure of human papillomavirus vaccine state requirements. Clin Pharmacol Ther 2007;82:760-3.
22. Freed GL, Cowan AE, Gregory S, Clark SJ. Variation in provider vaccine purchase prices and payer reimbursement. Pediatrics 2008;122:1325-31.
23. Hammer LD, Curry ES, Harlor AD, Laughlin JJ, Leeds AJ, Lessin HR, et al. Policy statement increasing immunization coverage. Pediatrics 2010;125:1295-304.
24. Centers for Disease Control and Prevention (US). Universally recommended vaccinations: reducing client out-of-pocket costs for vaccinations [cited 2010 Nov 2]. Available from: URL: http://www.thecommunityguide.org/vaccines/universally/clientoutofpocket costs.html
25. Centers for Disease Control and Prevention (US). VFC operations guide [cited 2010 Nov 4]. Available from: URL: http://www.cdc.gov/vaccines/programs/vfc/operations-guide.htm
26. Rand CM, Shone LP, Albertin C, Auinger P, Klien J, Szilagyi PG. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med 2007;161:252-9.
27. Oster NV, McPhillips-Tangum CA, Averhoff F, Howell K. Barriers to adolescent immunization: a survey of family physicians and pediatricians. J Am Board Fam Pract 2005;18:13-9.
28. Rand CM, Szilagyi PG, Albertin C, Auinger P. Additional health care visits needed among adolescents for human papillomavirus vaccine delivery within medical homes: a national study. Pediatrics 2007;120:461-6.
29. Minkovitz CS, Belote AD, Higman SM, Serwint JR, Weiner JP. Effectiveness of a practice-based intervention to increase vaccination rates and reduce missed opportunities. Arch Pediatr Adolesc Med 2001;155:382-6.
30. Centers for Disease Control and Prevention (US). Universally recommended vaccinations: client reminder & recall systems [cited 2010 Nov 2]. Available from: URL: http://www.thecommunityguide.org/ vaccines/universally/clientreminder.html
31. Szilagyi PG, Bordley C, Vann JC, Chelminski A, Kraus RM, Margolis PA, et al. Effect of patient reminder/recall interventions on immunization rates. JAMA 2000;284:1820-7.
32. Lee GM, Lorick SA, Pfoh E, Kleinman K, Fishbein D. Adolescent immunizations: missed opportunities for prevention. Pediatrics 2008;122:711-7.
33. Lindley MC, Boyer-Chu L, Fishbein DB, Kolasa M, Middleman AB, Wilson T, et al. The role of schools in strengthening delivery of new adolescent vaccinations. Pediatrics 2008;121 Suppl 1:S46-54.